Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damian A Laber

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.
Stem Cells (Dayton, Ohio)|March 15, 2008
Mobilization of hematopoietic progenitor cells by yeast-derived beta-glucan requires activation of matrix metalloproteinase-9Daniel E Cramer, Stephanie Wagner, Bing Li, et al.
JAMA Network Open|June 26, 2023
Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal CancerLingbin Meng, Ram Thapa, Maria G Delgado, et al.
Investigational New Drugs|November 19, 2013
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinomaJonathan E Rosenberg, Richard M Bambury, Eliezer M Van Allen, et al.
Contemporary Clinical Trials Communications|March 5, 2024
Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trialKea Turner, Dae Won Kim, Brian D Gonzalez, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Journal of Cancer Research and Clinical Oncology|June 3, 2006
A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanomaDamian A Laber, Roseline I Okeke, Carlos Arce-Lara, et al.
Stem Cells (Dayton, Ohio)|March 15, 2008
Mobilization of hematopoietic progenitor cells by yeast-derived beta-glucan requires activation of matrix metalloproteinase-9Daniel E Cramer, Stephanie Wagner, Bing Li, et al.
JAMA Network Open|June 26, 2023
Association of Age With Treatment-Related Adverse Events and Survival in Patients With Metastatic Colorectal CancerLingbin Meng, Ram Thapa, Maria G Delgado, et al.
Investigational New Drugs|November 19, 2013
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinomaJonathan E Rosenberg, Richard M Bambury, Eliezer M Van Allen, et al.
Contemporary Clinical Trials Communications|March 5, 2024
Support Through Remote Observation and Nutrition Guidance (STRONG), a digital health intervention to reduce malnutrition among pancreatic cancer patients: A study protocol for a pilot randomized controlled trialKea Turner, Dae Won Kim, Brian D Gonzalez, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Pageof 5